These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of garlic (Allium sativum) oil on exercise tolerance in patients with coronary artery disease. Verma SK; Rajeevan V; Jain P; Bordia A Indian J Physiol Pharmacol; 2005 Jan; 49(1):115-8. PubMed ID: 15881870 [TBL] [Abstract][Full Text] [Related]
5. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM; Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761 [TBL] [Abstract][Full Text] [Related]
6. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?]. Pöss J; Böhm M; Laufs U Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597 [TBL] [Abstract][Full Text] [Related]
7. [Does diabetes affect the choice of pharmaceutical treatment in coronary artery disease?]. Collet JP; Montalescot G Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():51-7. PubMed ID: 15666483 [TBL] [Abstract][Full Text] [Related]
8. Lipid management in Type 1 diabetes. Pachaiappan KJ; Patel V; Morrissey J; Gadsby R Diabet Med; 2006 Mar; 23 Suppl 1():11-4. PubMed ID: 16483259 [No Abstract] [Full Text] [Related]
9. Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study. James P; Tan HH; MacAlpine R; Brennan G; Emslie-Smith A; Morris AD Diabet Med; 2004 Oct; 21(10):1108-12. PubMed ID: 15384958 [TBL] [Abstract][Full Text] [Related]
10. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Mozaffarian D Altern Ther Health Med; 2005; 11(3):24-30; quiz 31, 79. PubMed ID: 15945135 [TBL] [Abstract][Full Text] [Related]
11. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Nau DP; Mallya U Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854 [TBL] [Abstract][Full Text] [Related]
12. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. Reasner CA J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366 [TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries: is cinnamon safe and effective for treating lipid disorders? Letinsky D; Kelsberg G; St Anna L J Fam Pract; 2011 Jan; 60(1):43-4. PubMed ID: 21209980 [No Abstract] [Full Text] [Related]
15. Alpha-linolenic acid: a gift from the land? Harris WS Circulation; 2005 Jun; 111(22):2872-4. PubMed ID: 15939831 [No Abstract] [Full Text] [Related]
16. Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes. Aguilar-Salinas CA; Mehta R; Gomez-Diaz RA Curr Diab Rep; 2012 Jun; 12(3):221-3. PubMed ID: 22451238 [No Abstract] [Full Text] [Related]
17. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group. Steiner G Diabetologia; 1996 Dec; 39(12):1655-61. PubMed ID: 9081851 [TBL] [Abstract][Full Text] [Related]
18. Lipid management in patients with diabetes mellitus. Brown AS Am J Cardiol; 2005 Aug; 96(4A):26E-32E. PubMed ID: 16098840 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416 [TBL] [Abstract][Full Text] [Related]